Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Last Published 01.01.2026 Effective Date: 01.01.2026 This policy addresses the use of Gazyva (obinutuzumab) for intravenous infusion for active lupus nephritis
Afamelanotide: An Orphan Drug with Potential for Broad Dermatologic Applications
Even the approved 4g/day dose for two weeks can raise liver enzyme levels in about a third of patients
The iron-regulatory hormone hepcidin: a possible therapeutic target
US$ 27.50
US$ 26.51
US$ 29.27
US$ 21.24
US$ 24.49
US$ 24.46
US$ 28.96
US$ 20.86
US$ 23.98
